Metabolic response to surgery in infants and children

M McHoney1, S Eaton, A Pierro

  • 1UCL Institute of Child Health and Great Ormond Street Hospital, Paediatric Surgery, London, United Kingdom. merrill@doctors.org.uk

Insights

Paediatric surgery has advanced with better understanding of metabolic responses. Minimally invasive techniques may preserve metabolic processes and thermoregulation in children, warranting further study.

Area of Science:

  • Pediatric Surgery
  • Surgical Physiology
  • Metabolic Response

Background:

  • Significant advancements in pediatric surgery over the past two decades.
  • Improved understanding of physiological responses to surgery and metabolic alterations.
  • Minimally invasive surgery is now a standard approach for various pediatric conditions.

Purpose of the Study:

  • To analyze the metabolic response to surgery in neonates, infants, and children.
  • To compare metabolic responses in pediatric patients with adult responses.
  • To investigate the impact of minimally invasive surgery on metabolic and thermoregulatory processes in children.

Main Methods:

  • Review of existing literature on pediatric surgical metabolic responses.
  • Analysis of postoperative changes in oxygen consumption and resting energy expenditure.
  • Comparison of metabolic patterns between neonates, infants, older children, and adults.

Main Results:

  • Neonates exhibit a small, transient increase in resting energy expenditure post-surgery.
  • Infants show a greater increase in energy expenditure after major surgery, potentially diverting energy from growth.
  • Older children may have a different pattern, with an initial fall in energy expenditure, unlike adult late hypermetabolism.

Conclusions:

  • Pediatric metabolic responses to surgery differ from adults, influenced by factors like thermoregulation.
  • Minimally invasive surgery might preserve preoperative metabolic states and thermoregulation in children.
  • Further research is needed to elucidate the mechanisms and benefits of these observations in pediatric surgical patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...